Moctar Chaibou | Pharmacology | Best Researcher Award

Best Researcher Award

Moctar Chaibou
Université Abdou Moumouni, Niger

Moctar Chaibou
Affiliation Université Abdou Moumouni
Country Niger
Documents 1
Subject Area Pharmacology
Event International Popular Scientist Awards
ORCID 0009-0005-6832-4153

Moctar Chaibou is a researcher affiliated with Université Abdou Moumouni in Niger whose stated subject area is pharmacology. The available profile information records one indexed document and identifies pharmacology as the principal research area supplied for this recognition profile. The Best Researcher Award profile is intended to present the available academic information in a structured and neutral manner while distinguishing documented information from bibliometric indicators that were not supplied.

Abstract

This academic recognition profile presents the available information concerning Moctar Chaibou, a researcher affiliated with Université Abdou Moumouni, Niger, and associated with the field of pharmacology. The supplied bibliographic record indicates one document. The profile is prepared in the context of the International Popular Scientist Awards and the Best Researcher Award, with emphasis on research affiliation, subject-area relevance, documented scholarly output, and the potential contribution of pharmacological research to biomedical and health-related knowledge. [1]

Keywords

Moctar Chaibou; Best Researcher Award; Université Abdou Moumouni; Niger; Pharmacology; pharmaceutical research; biomedical science; research recognition; International Popular Scientist Awards; ORCID.

Introduction

Pharmacology is an interdisciplinary scientific field concerned with the study of drugs, biologically active substances, their mechanisms of action, therapeutic applications, and interactions with biological systems. Research in the discipline can contribute to the understanding of disease mechanisms, therapeutic development, drug safety, and evidence-based approaches to medicine. Within this broader context, researcher recognition may consider documented scholarly activity alongside the relevance, rigor, and potential significance of an individual’s research.[1]

Research Profile

The supplied research profile places Moctar Chaibou within pharmacology and associates the researcher with Université Abdou Moumouni in Niger. The institutional affiliation provides an academic setting for research and scholarly activity, while the stated subject area establishes the disciplinary context for evaluating the documented work.

Research Contributions

The available information does not provide sufficient bibliographic detail to attribute specific experimental findings, methodologies, clinical applications, or research discoveries to Moctar Chaibou beyond the stated association with pharmacology. Accordingly, this section does not assign unsupported claims to the researcher. A comprehensive assessment of research contributions would ordinarily examine the topics addressed in publications, methodological approaches, originality, reproducibility, scholarly collaboration, and relevance to pharmacological science.

Publications

The supplied profile records one document. However, no publication title, journal name, publication year, author list, volume, issue, pages, or DOI was included in the source information provided for this article. Consequently, no specific publication citation or DOI is attributed here. The absence of a supplied DOI should not be interpreted as evidence that the documented work lacks a DOI; bibliographic verification would be required.

Research Impact

Research impact can be evaluated through several complementary dimensions, including scholarly citations, publication quality, methodological contribution, collaboration, translation into practice, education, and broader societal relevance. For pharmacological research, impact may also be reflected in contributions to therapeutic understanding, drug development, safety assessment, and evidence-based healthcare.[1]

Award Suitability

The Best Researcher Award associated with the International Popular Scientist Awards provides a recognition framework in which a researcher’s disciplinary engagement, scholarly record, research relevance, and documented academic activity may be considered. In the case of Moctar Chaibou, the supplied information establishes an academic affiliation with Université Abdou Moumouni, a research focus in pharmacology, and one documented indexed document.

Conclusion

Moctar Chaibou is identified as a researcher affiliated with Université Abdou Moumouni in Niger and working within the subject area of pharmacology. The supplied academic profile records one document and provides an ORCID identifier, while citation and h-index information remains unspecified. [1]

References

  1. Elsevier. (n.d.). Scopus author details: Moctar Chaibou.
  2. ORCID. (n.d.). ORCID record for Moctar Chaibou.
    https://orcid.org/0009-0005-6832-4153
  3. Chaibou, M., Ouédraogo, R. J., Nguyen, A., Mbeng Obame, R. B., Le Pogam-Alluard, P., Moussa, I., Beniddir, M., & Ikhiri, K. (2026). In silico docking and computational metabolomic approaches for antiparasitic drugs discovery from Boscia senegalensis (Capparaceae), a medicinal plant of Niger pharmacopoeia.

Atyurmila Chakraborty | Pharmacology | Best Researcher Award

Best Researcher Award

         Atyurmila Chakraborty
Affiliation SRM Institute of Science and Technology, Kattankulathur
Country India
Scopus ID 57808966100
Documents 15
Citation 46 citations (40 citing documents)
h-index 4
Subject Area Pharmacology
Event International Popular Scientist Awards
ORCID 0000-0002-1770-5491

Atyurmila Chakraborty

SRM Institute of Science and Technology, Kattankulathur, India

Atyurmila Chakraborty  the Best Researcher Award recognizes sustained scholarly activity, research productivity, and contributions to scientific knowledge through peer-reviewed publications, academic engagement, and measurable research impact. Atyurmila Chakraborty is affiliated with SRM Institute of Science and Technology, Kattankulathur, India, with research indexed in Scopus under Author ID 57808966100. Available bibliometric indicators demonstrate active scholarly contributions within the field of pharmacology and related biomedical sciences.[1]

Abstract

This article presents an academic overview of Atyurmila Chakraborty’s research profile in relation to the Best Researcher Award. The assessment considers scholarly productivity, publication record, citation performance, subject specialization, and professional visibility through internationally recognized indexing services. The available bibliometric information indicates active participation in pharmacology research and continued contribution to peer-reviewed scientific literature.[1]

Keywords

Best Researcher Award; Pharmacology; Scopus Author; Scientific Publications; Citation Analysis; Research Impact; Biomedical Research; Academic Excellence; International Popular Scientist Awards.

Introduction

Academic recognition programs acknowledge researchers who consistently contribute to scientific advancement through rigorous investigation, publication, collaboration, and dissemination of knowledge. Bibliometric indicators such as indexed publications, citations, and the h-index provide standardized measures that complement expert peer evaluation during award assessment processes.[2]

Research Profile

Atyurmila Chakraborty’s research profile demonstrates engagement with pharmacological sciences through scholarly publications indexed in Scopus. The available metrics include fifteen indexed documents, forty-six citations, and an h-index of four. These indicators reflect an active research portfolio and measurable scholarly visibility within the academic community.[1]

Research Contributions

Research contributions within pharmacology commonly encompass experimental studies, therapeutic investigations, drug discovery, toxicological evaluation, pharmacokinetic analysis, and translational biomedical research. Scholarly publications contribute to scientific communication by presenting validated methodologies, reproducible findings, and evidence-based interpretations for the wider research community.[2]

Publications

The available Scopus profile records fifteen indexed scholarly documents. Publications indexed by international databases contribute to citation visibility, research accessibility, and scholarly evaluation. Where applicable, published articles include Digital Object Identifiers (DOIs), enabling persistent identification and reliable academic referencing.[1][3]

Research Impact

Research impact is commonly evaluated through publication quality, citation frequency, scholarly collaboration, and sustained contribution to disciplinary knowledge. Citation metrics, together with peer-reviewed publications and recognized author profiles, provide objective evidence supporting research visibility and scientific influence.[2]

Award Suitability

Based on the publicly available academic indicators, Atyurmila Chakraborty demonstrates characteristics commonly considered during evaluations for the Best Researcher Award, including indexed publications, measurable citation performance, an established Scopus author profile, and active research engagement in pharmacology. Final award decisions remain dependent upon comprehensive review criteria established by the organizing committee of the International Popular Scientist Awards.[4]

Conclusion

Atyurmila Chakraborty’s documented scholarly profile illustrates ongoing participation in pharmacology research supported by internationally indexed publications and recognized bibliometric indicators. Such academic achievements represent important components of professional research evaluation and provide a foundation for consideration within competitive scientific recognition programs.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Atyurmila Chakraborty, Author ID 57808966100. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57808966100
  2. Hirsch, J. E. (2005). An index to quantify an individual’s scientific research output. Proceedings of the National Academy of Sciences.
  3. International DOI Foundation. (n.d.). Digital Object Identifier (DOI) Handbook.
  4. International Popular Scientist Awards. (n.d.). Award information and nomination guidelines.
    https://popularscientist.com/

Lili Gu | Pharmacology | Women Researcher Award

Assoc. Prof. Dr. Lili Gu | Pharmacology | Women Researcher Award

Assoc. Prof. Dr. at Hangzhou Medical College | China

Assoc. Prof. Dr. Lili Gu is a researcher in pharmacology with expertise in neurodegenerative diseases, focusing on mechanisms underlying Alzheimer’s disease and neuroinflammation. Her work explores bioactive compounds, including flavonoids and andrographolide derivatives, targeting pathways such as autophagy, NLRP3 inflammasome, and LRP1-mediated signaling. She has contributed to advancing understanding of neuroprotection through experimental and network-based approaches, integrating molecular pharmacology with traditional medicine insights. Her research outputs include peer-reviewed publications in high-impact journals, demonstrating strong contributions to therapeutic discovery. Professionally, she has progressed through academic and research roles, gaining extensive experience in teaching, scientific investigation, and collaborative project development within pharmaceutical sciences.

Citation Metrics (Scopus)

500

400

300

200

100

0

Citations
412

Documents
33

h-index
12

🟦 Citations    🟥 Documents    🟩 h-index


View Scopus Profile

Featured Publications

Sabastine Zubairu | Pharmacology | Excellence in Research Award

Dr. Sabastine Zubairu | Pharmacology | Excellence in Research Award

Senior Lecturer at Gombe State University | Nigeria

Dr. Sabastine Zubairu is a pharmacologist specializing in experimental toxicology, chronopharmacology, and oxidative stress biology with a strong focus on drug-induced organ toxicity and diabetes-related complications. His research explores how biological timing and environmental factors influence drug safety, integrating biochemical, histological, and physiological approaches. He has contributed to understanding diurnal variations in nephrotoxicity and mechanisms underlying drug interactions and metabolic disorders. His work spans molecular pharmacology, toxicological screening, and natural product research, with growing interest in predictive and computational toxicology using data-driven and systems-level approaches to enhance precision dosing, drug discovery, and translational pharmacological outcomes.

Citation Metrics (Google Scholar)

1000

800

600

400

200

0

Citations
703

i10index
32

h-index
17

🟦 Citations    🟥 i10-index    🟩 h-index


View Google Scholar          View ORCID

Featured Publications